PT-141 source due diligence
PT-141 (bremelanotide) Canada: COA and batch check before you buy
Buying PT-141 for research in Canada? Check lot LNX-2507-2613, COA-2025-8006, 99.39% purity (document values) before ordering.
Route PT-141 demand into a source record
PT-141 Canada searches are compound-specific, but the useful next step is still documentation: exact Bremelanotide identity, the current 10 mg product and batch record, COA access, stated fill, storage notes, Canadian fulfillment context, and a saved URL before an order is considered.
Keep melanocortin family records separate
PT-141 belongs in an MC4R-oriented central melanocortin source file distinct from broader melanocortin analogues such as Melanotan-2, and clearly separate from unrelated lanes such as Kisspeptin-10 (KISS1R/GnRH) and Selank. Material identity, receptor scope, analytical evidence, and handling assumptions differ; similar catalogue placement is not evidence of equivalence.
PT-141 certificate checkpoint: 18 October 2026
The linked certificate COA-2025-8006 labels the sample PT-141 (Bremelanotide) 10mg and identifies lot LNX-2507-2613 (printed with a leading #). It reports 99.39% purity, a detected quantity of 10.15 mg, a reported date of 2025-07-12, and an appearance of white lyophilized powder. The detected quantity is a reported sample result, not the nominal 10 mg catalogue label or a guarantee for every vial. The certificate does not report endotoxin or moisture results; do not infer them from the purity figure.
Check method and date labels against the original report
The analytical heading states HPLC-UV coupled with mass spectrometry, while the footer uses LC-MS/MS wording. This checklist preserves both labels without reconciling them or independently validating the results. Request the original laboratory report, method details, and clarification of the date sequence before relying on this document for institutional acceptance.
Re-check the trail when the lot changes
A familiar product name does not make a replacement lot equivalent. Re-open the product page, match the displayed batch reference to the current COA, confirm the stated fill, purity method, and storage language, and save any support clarification with the procurement record before returning to checkout.
What this page cannot establish
- The certificate states that its results apply only to the named lot. This dated checkpoint does not document replacement lots, other fill sizes, or materials blended or mislabelled under the PT-141 name.
- A reported purity percentage is not a sterility or endotoxin result, clinical approval, or evidence of suitability for administration. This material is for laboratory research only, not human or animal use.
- Lynx Labs branding and its quality-assurance contact do not establish an independent testing laboratory. Request laboratory identity, accreditation and original analytical records where required.
- The COA checklist tool can flag missing fields but cannot authenticate a document, resolve its date sequence, or replace laboratory verification.
Sources and verification paths
Use these records to verify identity and current documentation. Re-check live product records when the lot or variant changes.
Research-use-only FAQ
Where can I buy PT-141 for research in Canada?
Lynx Labs lists PT-141 (bremelanotide) 10 mg as a research-use-only material and ships from Canada. Review the live record at /products/pt-141 and verify lot LNX-2507-2613 against certificate COA-2025-8006 (99.39% purity, document values) before ordering. Not for human or animal use.
Does the displayed PT-141 COA verify the current 10 mg variant?
The linked certificate COA-2025-8006 labels the sample PT-141 (Bremelanotide) 10mg, identifies lot LNX-2507-2613, and reports 99.39% purity and 10.15 mg detected quantity for that sample. Those are document values for the named lot; they do not establish a fill tolerance, a replacement lot, or results for every vial. Match the certificate to the current variant and received vial before ordering.
Is PT-141 the same as Melanotan-2?
No. Both are melanocortin-relevant materials, but PT-141 (bremelanotide) is positioned around MC4R-oriented central melanocortin signalling, while Melanotan-2 is a broader melanocortin analogue typically discussed for receptor-breadth and comparator research. Their identity, receptor scope, and analytical records are not interchangeable; keep each in its own source file.
Is this a PT-141 use guide?
No. This page is limited to research-use-only source evaluation: material identity, the displayed 10 mg lot COA, analytical method, stated fill, storage notes, Canadian fulfillment, and claim-boundary review. It is not sexual-health advice, personal-use guidance, route guidance, or treatment information.
What should be saved before comparing PT-141 source pages?
Save the current product URL, exact material name, stated fill, visible lot or batch reference, COA path, purity method, storage language, support clarification if needed, and the date the record was checked.
Ready to inspect current records?
LynxLabs product pages are for research-use-only procurement review. They are not dosing guides, treatment recommendations, or personal-use protocols.
Shop now